AtheroGenics Incorporated

AtheroGenics is an emerging pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, rheumatoid arthritis and asthma.

AtheroGenics has cultivated a drug discovery and development capability directed toward rapidly creating and transporting small molecule therapeutics into the clinical testing arena to ultimately establish the safety and efficacy of novel compounds that address serious unmet medical needs

Contact Details: 8995 Westside Parkway Alpharetta 30004 United States of America Tel: 678 336 2500 Fax: 770 447 1886 Email: investor@atherogenics.com. WWW: www.atherogenics.com/

Recent Publications by AtheroGenics Incorporated:
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases. Starting from a simple chalcone template, structure-activity relationship...	28th April, 2007	AtheroGenics, Inc., 8995 Westside Parkway, Alpharetta, Georgia 30004, USA.	J Med Chem. 2007 Mar 22;50(6):1304-15. Epub 2007 Feb 27. DOI Direct Link
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. The antioxidant response element (ARE) is a transcriptional control...	2nd June, 2006	Discovery Research, AtheroGenics, Incorporated, Alpharetta, GA 30004, USA.	Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1862-70. Epub 2005 Dec DOI Direct Link
Atherosclerosis is an inflammatory disorder after all. Inflammation has been increasingly recognized as an important player in...	11th May, 2006	AtheroGenics, Inc., 8995 Westside Parkway, Alpharetta, Georgia 30004, USA.	Curr Top Med Chem. 2006;6(2):93-102.
Oral cholesteryl ester transfer protein (CETP) inhibitors: a potential new approach for treating coronary artery disease. Inflammation has been increasingly recognized as an important player in...	17th February, 2006	Discovery Medicinal Chemistry, AtheroGenics, Inc., 8995 Westside Parkway,	J Med Chem. 2006 Jan 12;49(1):1-22. DOI Direct Link
Inflammation in atherosclerosis: new opportunities for drug discovery. Many lines of evidence indicate that inflammation is the ultimate cause of...	23rd February, 2005	AtheroGenics, Inc., 8995 Westside Parkway, Alpharetta, Georgia 30004, USA.	Mini Rev Med Chem. 2005 Jan;5(1):33-40.
→View more AtheroGenics Incorporated research publications.

BioNews Results for AtheroGenics Incorporated:
Is Bigger Really Better?	Signals Magazine:  Aug 29 2008 3:44AM Matching: atherogenics
AtheroGenics Gets Good News From Phase III Trial for Diabetes	FDA News:  Aug 5 2008 11:35PM Matching: atherogenics
AtheroGenics records $14M second-quarter deficit	East Bay Business Journal:  Aug 5 2008 4:34PM Matching: atherogenics
AtheroGenics Reports Second Quarter 2008 Financial Results	Therapeutics Daily:  Aug 5 2008 2:07PM Matching: atherogenics
AtheroGenics Gets Good News From Phase III Trial for Diabetes	FDA News:  Aug 5 2008 10:32PM Matching: atherogenics
Promote your company here: BioNewsCast - Press Release Distribution	→View more AtheroGenics Incorporated news.

AtheroGenics Incorporated Patents:
US Patent No.	Title
7375252	Compounds and method for the inhibition of the expression of VCAM-1
6881860	Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
6852878	Thioketals and thioethers for inhibiting the expression of VCAM-1
6828447	Compounds and methods for the inhibition of the expression of VCAM-1
6747061	N-substituted dithiocarbamates for the treatment of biological disorders
→View more AtheroGenics Incorporated patents.

AtheroGenics Incorporated (AGIX) Financial information Links from Barchart
AGIX Quote from from Barchart.com
AGIX Chart from from Barchart.com
AGIX Profile from from Barchart.com
AGIX Opinion from from Barchart.com
→View more AtheroGenics Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 209 times since April 2007, the link to the organisation's website has been followed 42 times

Recent Search Terms used to find this page: AtheroGenics Incorporated | .

Search for more companies in Alpharetta

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AtheroGenics Incorporated